Gambaran Umum
Lantheus Holdings, Inc., based in the United States, is a prominent player in the healthcare sector, specializing in diagnostic imaging and targeted radiotherapeutics. The company develops, manufactures, and commercializes essential radiopharmaceutical agents and products pivotal for diagnostic imaging procedures and disease treatment. Key products include PyL (piflufolastat F 18) used for prostate cancer imaging, and DEFINITY, an ultrasound enhancing agent for use in patients with suboptimal echocardiograms. Lantheus is continuously advancing in the field of precision diagnostics and therapeutics with a strong focus on developing innovative products that improve clinical outcomes and contribute to significant advancements in medical imaging and oncology. The company's strategic initiatives are heavily geared towards expanding its pipeline in radiopharmaceuticals to address various critical healthcare needs.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Lantheus Holdings, Inc. per 2025 Jun 30 adalah 1,520.65 MM.
- Nilai operating income untuk Lantheus Holdings, Inc. per 2025 Jun 30 adalah 432.79 MM.
- Nilai net income untuk Lantheus Holdings, Inc. per 2025 Jun 30 adalah 271.00 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1,520.65 | 432.79 | 271.00 |
2025-03-31 | 1,536.70 | 452.28 | 254.32 |
2024-12-31 | 1,533.91 | 445.87 | 312.44 |
2024-09-30 | 1,496.80 | 474.54 | 427.61 |
2024-06-30 | 1,438.01 | 452.66 | 428.48 |
2024-03-31 | 1,365.62 | 471.09 | 460.53 |
2023-12-31 | 1,296.43 | 493.37 | 326.66 |
2023-09-30 | 1,205.60 | 184.00 | 104.10 |
2023-06-30 | 1,124.94 | 157.89 | 33.37 |
2023-03-31 | 1,026.96 | 99.93 | -17.70 |
2022-12-31 | 935.06 | 36.20 | 28.07 |
2022-09-30 | 801.46 | 172.49 | 107.04 |
2022-06-30 | 664.24 | 81.96 | 32.39 |
2022-03-31 | 541.58 | -8.02 | -37.33 |
2021-12-31 | 425.21 | -66.59 | -71.28 |
2021-09-30 | 389.80 | -29.31 | -34.48 |
2021-06-30 | 376.27 | -27.27 | -27.45 |
2021-03-31 | 341.21 | 2.86 | -7.80 |
2020-12-31 | 339.41 | 10.40 | -13.47 |
2020-09-30 | 334.60 | 27.44 | 0.39 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | 3.68 | 3.53 |
2024-12-31 | 4.52 | 4.36 |
2024-09-30 | 6.20 | 6.02 |
2024-06-30 | 6.23 | 6.07 |
2024-03-31 | 6.72 | 6.50 |
2023-12-31 | 4.79 | 4.65 |
2023-09-30 | 1.52 | 1.49 |
2023-06-30 | 0.49 | 0.48 |
2023-03-31 | -0.26 | -0.25 |
2022-12-31 | 0.41 | 0.40 |
2022-09-30 | 1.57 | 1.52 |
2022-06-30 | 0.48 | 0.46 |
2022-03-31 | -0.55 | -0.56 |
2021-12-31 | -1.06 | -1.06 |
2021-09-30 | -0.51 | -0.51 |
2021-06-30 | -0.41 | -0.41 |
2021-03-31 | -0.13 | -0.13 |
2020-12-31 | -0.25 | -0.25 |
2020-09-30 | 0.01 | 0.01 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Lantheus Holdings, Inc. per 2025 Jun 30 adalah 527.46 MM.
- Nilai cash from investing activities untuk Lantheus Holdings, Inc. per 2025 Jun 30 adalah -370.59 MM.
- Nilai kas dari aktivitas pendanaan untuk Lantheus Holdings, Inc. per 2025 Jun 30 adalah -218.42 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 527.46 | -370.59 | -218.42 |
2025-03-31 | 525.08 | -183.20 | -119.91 |
2024-12-31 | 544.75 | -226.01 | -118.54 |
2024-09-30 | 499.31 | -231.48 | -15.33 |
2024-06-30 | 440.98 | -80.47 | -17.09 |
2024-03-31 | 324.00 | -56.08 | -21.24 |
2023-12-31 | 305.26 | 5.94 | -13.06 |
2023-09-30 | 298.32 | -246.72 | 305.23 |
2023-06-30 | 275.15 | -336.02 | 303.16 |
2023-03-31 | 380.02 | -319.67 | 305.20 |
2022-12-31 | 281.78 | -276.55 | 311.69 |
2022-09-30 | 190.32 | -16.37 | -8.25 |
2022-06-30 | 101.09 | -12.70 | -8.02 |
2022-03-31 | 54.36 | -11.01 | -6.72 |
2021-12-31 | 53.92 | 3.68 | -39.33 |
2021-09-30 | 40.60 | 4.44 | -41.60 |
2021-06-30 | 44.83 | 3.13 | -47.15 |
2021-03-31 | 16.81 | 11.09 | -52.92 |
2020-12-31 | 16.40 | -4.91 | -21.86 |
2020-09-30 | 38.25 | -5.87 | -20.31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk Lantheus Holdings, Inc. pada 2025 Jun 30 adalah 0.13.
- roe untuk Lantheus Holdings, Inc. pada 2025 Jun 30 adalah 0.26.
- roic untuk Lantheus Holdings, Inc. pada 2025 Jun 30 adalah 0.14.
- croic untuk Lantheus Holdings, Inc. pada 2025 Jun 30 adalah 0.12.
- ocroic untuk Lantheus Holdings, Inc. pada 2025 Jun 30 adalah 0.29.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.13 | 0.26 | 0.14 | 0.12 | 0.29 |
2025-03-31 | 0.14 | 0.27 | 0.14 | 0.12 | 0.29 |
2024-12-31 | 0.28 | 0.61 | 0.18 | 0.11 | 0.21 |
2024-09-30 | 0.28 | 0.61 | 0.18 | 0.11 | 0.21 |
2024-06-30 | 0.34 | 1.03 | 0.29 | 0.16 | 0.21 |
2024-03-31 | 0.25 | 0.73 | 0.23 | 0.21 | 0.21 |
2023-12-31 | 0.09 | 0.16 | 0.08 | 0.27 | 0.23 |
2023-09-30 | 0.03 | 0.06 | 0.03 | 0.21 | 0.24 |
2023-06-30 | 0.03 | 0.06 | 0.03 | 0.21 | 0.24 |
2023-03-31 | -0.02 | -0.03 | -0.02 | 0.35 | 0.37 |
2022-12-31 | 0.13 | 0.21 | 0.13 | 0.20 | 0.23 |
2022-09-30 | 0.13 | 0.21 | 0.13 | 0.20 | 0.23 |
2022-06-30 | 0.04 | 0.06 | 0.04 | 0.11 | 0.13 |
2022-03-31 | -0.04 | -0.07 | -0.05 | 0.05 | 0.08 |
2021-12-31 | -0.08 | -0.14 | -0.11 | 0.03 | 0.08 |
2021-09-30 | -0.04 | -0.07 | -0.05 | 0.01 | 0.06 |
2021-06-30 | -0.03 | -0.05 | -0.04 | 0.00 | 0.06 |
2021-03-31 | -0.02 | -0.07 | -0.01 | -0.03 | 0.02 |
2020-12-31 | -0.03 | -0.12 | -0.02 | -0.01 | 0.02 |
2020-09-30 | 0.00 | 0.00 | 0.00 | 0.02 | 0.05 |
Gross Margins
- marjin kotor untuk Lantheus Holdings, Inc. pada 2025 Jun 30 adalah 0.64.
- marjin bersih untuk Lantheus Holdings, Inc. pada 2025 Jun 30 adalah 0.17.
- marjin operasi untuk Lantheus Holdings, Inc. pada 2025 Jun 30 adalah 0.29.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.64 | 0.17 | 0.29 |
2025-03-31 | 0.64 | 0.17 | 0.29 |
2024-12-31 | 0.73 | 0.29 | 0.41 |
2024-09-30 | 0.73 | 0.29 | 0.41 |
2024-06-30 | 0.73 | 0.34 | 0.45 |
2024-03-31 | 0.55 | 0.25 | 0.28 |
2023-12-31 | 0.64 | 0.09 | 0.15 |
2023-09-30 | 0.64 | 0.03 | 0.14 |
2023-06-30 | 0.64 | 0.03 | 0.14 |
2023-03-31 | 0.63 | -0.02 | 0.10 |
2022-12-31 | 0.59 | 0.13 | 0.30 |
2022-09-30 | 0.59 | 0.13 | 0.30 |
2022-06-30 | 0.55 | 0.05 | 0.23 |
2022-03-31 | 0.51 | -0.07 | 0.12 |
2021-12-31 | 0.44 | -0.17 | 0.01 |
2021-09-30 | 0.43 | -0.09 | 0.01 |
2021-06-30 | 0.43 | -0.07 | -0.07 |
2021-03-31 | 0.42 | -0.02 | 0.01 |
2020-12-31 | 0.43 | -0.04 | 0.05 |
2020-09-30 | 0.45 | 0.00 | 0.08 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1521036 |
Grupong Pang-industriya
SIC 2835 - In Vitro and In Vivo Diagnostic Substances |